Building Blocks in the Case for Adjuvant Therapy in Biliary Tract Cancers

Published: May 11, 2015, 8 p.m.

This podcast places the results of SWOG S0809, a phase II intergroup trial of adjuvant capecitabine/gemcitabine followed by radiotherapy and concurrent capecitabine in extrahepatic cholangiocarcinoma and gallbladder carcinoma, in context with prior conflicting data and discusses implications for development of a definitive phase III trial.